{"id":168182,"date":"2024-01-04T02:37:52","date_gmt":"2024-01-04T07:37:52","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/hepion-pharmaceuticals-to-present-at-nash-tag-2024\/"},"modified":"2024-08-18T11:47:09","modified_gmt":"2024-08-18T15:47:09","slug":"hepion-pharmaceuticals-to-present-at-nash-tag-2024","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/hepion-pharmaceuticals-to-present-at-nash-tag-2024.php","title":{"rendered":"Hepion Pharmaceuticals to Present at NASH-TAG 2024"},"content":{"rendered":"<p><![CDATA[EDISON, N.J., Jan.  03, 2024  (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (\u201cAI\u201d)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (\u201cNASH\u201d), fibrotic diseases, hepatocellular carcinoma (\u201cHCC\u201d), and other chronic diseases, today announced that an abstract highlighting its lead drug candidate, rencofilstat, will be presented at the 2024 NASH-TAG Conference, which is being held January 4-6, 2024, in Park City, Utah.]]><\/p>\n<p>Read the original here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/01\/03\/2803663\/0\/en\/Hepion-Pharmaceuticals-to-Present-at-NASH-TAG-2024.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Hepion Pharmaceuticals to Present at NASH-TAG 2024\">Hepion Pharmaceuticals to Present at NASH-TAG 2024<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read the original here: Hepion Pharmaceuticals to Present at NASH-TAG 2024 <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/hepion-pharmaceuticals-to-present-at-nash-tag-2024.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-168182","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/168182"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=168182"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/168182\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=168182"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=168182"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=168182"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}